David G. DeNardo

26.4k citations
110 papers · 15.3k indexed · 12 hit papers · h-index 49

Impact in

  • Immunology top 0.1%
    • Immune cells in cancer
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • Phagocytosis and Immune Regulation
  • Oncology top 0.1%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis
    • Pancreatic and Hepatic Oncology Research

Papers in

    • Immune cells in cancer 48
    • Immunotherapy and Immune Responses 18
    • Immune Cell Function and Interaction 12
    • Phagocytosis and Immune Regulation 10
    • Cancer Immunotherapy and Biomarkers 40
    • Pancreatic and Hepatic Oncology Research 28
    • Cancer Cells and Metastasis 9

David G. DeNardo

107 papers receiving 15.1k citations

Hit Papers

Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer 2024 · 56 citations
56200720262013201950010001.5k

Peers

David G. DeNardo
Comparison fields: 5 of 136
  • Immunology 9.0k
  • Oncology 8.7k
  • Cancer Research 2.3k
  • Molecular Biology 4.5k
  • Immunology and Allergy 383
Replace Brian Ruffell with:
Brian Ruffell United States
Elaine Y. Lin United States
Bin‐Zhi Qian United Kingdom
Jacqueline Bromberg United States
Daniela F. Quail Canada
Veena Kapoor United States
Marcin Kortylewski United States
Giorgio Stassi Italy
Stefani Spranger United States
Matilde Todaro Italy
David G. DeNardo relative to Brian Ruffell United States Brian Ruffell's profile →
Citations per field
00.5×1.5×1.9×
Brian Ruffell · 1×
Citations per year

Countries citing papers authored by David G. DeNardo

Since Specialization
Citations

This map shows the geographic impact of David G. DeNardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. DeNardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. DeNardo more than expected).

Fields of papers citing papers by David G. DeNardo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. DeNardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. DeNardo. The network helps show where David G. DeNardo may publish in the future.

Co-authors

The 25 scholars most cited alongside David G. DeNardo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David G. DeNardo Line = papers co-authored together David G. DeNardo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2
Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer
Hit paper breakdown →
202456
3 20243
4 202360
5 202344
6 20235
7 202233
8 202161
9 202092
10 201660
11 2015207
12 2014188
13
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
Hit paper breakdown →
2014974
14
Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
Hit paper breakdown →
2013479
15
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
Hit paper breakdown →
2012759
16
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
Hit paper breakdown →
20111320
17 201024
18
Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression
Hit paper breakdown →
2010523
19 200638
20 199821

About David G. DeNardo

David G. DeNardo is a scholar working on Immunology, Oncology, Cancer Research, Immunology and Allergy and Biotechnology, having authored 110 papers that have together received 15.3k indexed citations. Recurring topics across this work include Immune cells in cancer (48 papers), Cancer Immunotherapy and Biomarkers (40 papers), Pancreatic and Hepatic Oncology Research (28 papers), Immunotherapy and Immune Responses (18 papers), Immune Cell Function and Interaction (12 papers), Phagocytosis and Immune Regulation (10 papers), Cancer Cells and Metastasis (9 papers) and Epigenetics and DNA Methylation (7 papers). The work is most often cited by research in Immunology (9.0k citations), Oncology (8.7k citations), Cancer Research (2.3k citations), Molecular Biology (4.5k citations) and Immunology and Allergy (383 citations). David G. DeNardo has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Brian Ruffell, Lisa M. Coussens, Brett L. Knolhoff, Pauline Andreu, David C. Linehan, Andrea Wang‐Gillam, Yu Zhu, Brian L. West, Timothy M. Nywening and Magnus Johansson. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Cancer Cell, Clinical Cancer Research and Cancer Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026